CLINICAL ROLE -
New Pharmacy Benefit Manager Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Read More
Benefits of Value-Based Healthcare Highlights AJPB Week in Review
FDA Approves Once-Daily Neuropathic Pain Drug
Lyrica extended-release tablets treat neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia.
Uninsured Rate in the Suburbs Highlights AJPB Week in Review
New Formulation of Tardive Dyskinesia Drug Approved by FDA
Ingrezza is a selective VMAT2 inhibitor that was the first FDA-approved product indicated to treat adults with tardive dyskinesia.
Medicare Offerings for 2018 Highlights AJPB Week in Review
FDA Approves New Indication of Botox Drug for Moderate-to-Severe Forehead Lines
OnabotulinumtoxinA is a prescription medication that works by injection into the muscles to treat frontalis muscle activity.
Vitamin C Supplementation Highlights AJPB Week in Review
FDA Approves First Glucose Monitoring System to Reduce Need for Fingerstick Testing
System involves a small sensor wire inserted below the skin’s surface to continuously measure and monitor glucose in adults with diabetes.
FDA Orders Beauty Product Manufacturer to Halt Sale of Unapproved Medications
FDA states company sold unapproved and improperly labeled drugs that present serious public health risks, particularly sterile injectable skin whitening drug products.
FDA Approves First Single-Dose Therapy for Bacterial Vaginosis
Secnidazole (Solosec) oral granules granted approval to treat bacterial vaginosis in adult women.
Potentially Dangerous Ingredients in Candy Highlights AJPB Week in Review
FDA Concerns Over Multiple Myeloma Immunotherapy Highlights AJPB Week in Review
CVS Drug Pricing Lawsuit Dismissal Highlights AJPB Week in Review
Pharmacy Week in Review: September 1, 2017
A look at the top stories in pharmacy last week.
Highest-Selling Prescription Drugs of 2016 Highlights AJPB Week in Review
FDA Approves Generic Depressive Disorder Drug
Cymbalta is also indicated to treat general anxiety disorder in adults and children, fibromyalgia, or chronic muscle or joint pain, such as low back pain and osteoarthritis.
FDA Approvals Highlight AJPB Week in Review
FDA Guidances for Generic Drugs Highlights AJPB Week in Review
PBMs Release 2018 Formulary Lists Tops AJPB Week in Review
Pharmacy Week in Review: July 28, 2017
Pharmacy Group Speaks Out Against Medicare Reimbursement Plan
ASHP expresses concern over proposed cuts to Medicare payment rates for drugs that hospitals acquire under the 340B Drug Pricing Program.
Pharmacy Discount Card Concerns Highlights AJPB Week in Review
Interest in Mobile Health Technology Highlights AJPB Week in Review
Orphan Drug Evaluation Overhaul Highlights AJPB Week in Review
Prescription Drug Spending Projected to Grow This Year
“National trends in prescription drug expenditures and projections for 2017,” highlights total US prescription sales for the 2016 calendar year.
Blood, Lung Cancer Drug Approvals Highlight AJPB Week in Review
Texting System Helps Teens With Diabetes Improve Glycemic Control
Two-way text messaging system either maintained or improved A1C levels for teens with type 1 diabetes.
Medicare Drug Rebate Debate Highlights AJPB Week in Review
American Diabetes Association Joins With Walmart for 'Wellness Day'
One in 11 Americans has diabetes today, and 86 million more – about one in three – are at risk for developing type 2 diabetes.